secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scienture Holdings, Inc. (SCNX)
CIK:        0001382574
Form:       8-K
Filed at:   2022-11-07T23:59:59+00:00
Accession:  0001493152-22-030831
Event type: earnings
Sentiment:  neutral
Materiality: 0.55
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRxADE Q3 2022: revenue $2.4M (-6% YoY), gross margin 58%, net loss ($0.06)/share, adj EBITDA ($0.4M)
--------------------------------------------------------------------------------

- Revenue decreased 6% to $2.4M from $2.6M; gross margin improved to 58% from 50%.
- Net loss narrowed to ($0.5M) or ($0.06) per share vs ($1.3M) or ($0.16) per share YoY.
- Adjusted EBITDA turned negative at ($0.4M) compared to positive $0.7M in Q3 2021.
- Added 291 new registered members in Q3; total ~14,100+; Bonum Health signed telemedicine deal with ShopRite.
- Bonum Health entered distribution agreements with multiple insurance brokerage firms for employer groups in Oct 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382574/000149315222030831/0001493152-22-030831-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382574/000149315222030831/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-030831

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer